ARCHIVES

FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators

This article is from The Cancer Letter archive.

Vol. 40 No. 30 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

ASCO Expanding Tools To Improve Coordination Of Cancer Treatment

November 30, 2007

Obey Insists NCI Pressured IARC Into Softening Report On Benzene Risk

August 20, 1982

Preoperative Drug Combo Benefits HER-2 Breast Cancer

April 29, 2005

Rosenberg Begins Trial To Immunize Patient against Tumor

October 11, 1991

Animas As Early Warning “Sentinels” Part Of DCE Study

July 31, 1987

Senate Defeats Attempt To Cut NIH Funds

July 8, 1977